Synthetech Announces Date for Third Quarter Fiscal 2010 Earnings Release and Conference Call
Monday, Feb 08, 2010
Synthetech, Inc. today announced it will issue third quarter financial results before the opening of the market on Thursday, February 11, 2010. Following the release of its financial results, Synthetech will host a conference call at 1:30 p.m. PST. Dr. Gregory Hahn, President and CEO, along with Gary Weber, Vice President of Finance and CFO, will discuss results and be available to answer related questions.
The conference call can be accessed by dialing
About Synthetech
Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and proprietary custom chiral intermediates and specialty resins, primarily for the pharmaceutical industry. Synthetech produces advanced pharmaceutical intermediates in accordance with Current Good Manufacturing Practices (cGMP) in compliance with U.S. Food and Drug Administration (FDA) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production. Synthetech's products also support the production of chemically-based medical devices. Synthetech's domestic and international customer base includes major pharmaceutical, contract drug synthesis firms, emerging biotechnology (virtual pharmaceutical) and medical device companies. We also supply catalog quantities of specialty amino acids to research institutions, universities and drug discovery firms.
Source: PR Newswire
Bookmark with: